InMed to merge with Mentari in $290 million migraine therapy deal May 19, 2026 08:06AM
InMed Pharmaceuticals & Mentari Therapeutics Announce Merger to Advance Migraine Prevention Therapies May 19, 2026 08:00AM
/C O R R E C T I O N -- InMed Pharmaceuticals/ May 19, 2026 08:00AM
/C O R R E C T I O N -- InMed Pharmaceuticals/ May 19, 2026 08:00AM
InMed Pharmaceuticals to Participate in Cowen’s 4th Annual Cannabis Conference Nov 23, 2021 07:30AM


Nov 23, 2021 07:30AM InMed Pharmaceuticals to Participate in Cowen’s 4th Annual Cannabis Conference